Navigation Links
Post-Chemo Treatment May Boost Lung Cancer Survival
Date:5/20/2010

Study finds some benefit with erlotinib for people with non-small-cell form of disease

THURSDAY, May 20 (HealthDay News) -- Among people with non-small-cell lung cancer, treatment with the drug erlotinib (Tarceva) after chemotherapy appears to slightly boost survival rates, a new study suggests.

Non-small-cell lung cancer makes up about 85 percent of lung cancer cases. About half the time, people have advanced disease when diagnosed and are treated solely with chemotherapy, usually platinum-based chemo. But chemotherapy only boosts survival by eight to 10 months, the study authors noted.

The study findings, which support the use of erlotinib as a "maintenance" treatment, are based on research by Dr. Federico Cappuzzo of the Civil Hospital of Livorno in Italy and his colleagues. The researchers tested the drug in 889 people who'd had chemotherapy and whose disease had not gotten worse. They were randomly assigned to take erlotinib an inactive placebo.

According to the study, published online May 19 in The Lancet Oncology, the drug improved overall survival, compared with the placebo (12 months versus 11 months). The length of time without the disease progressing also was somewhat better for those who took the drug: 12 rather than 11 weeks. Most people tolerated the drug well, with skin rash and diarrhea being the most common side effect, the study found, but serious side effects affected 11 percent of those who took the drug, compared with 8 percent of those taking the placebo.

"The acceptable tolerability profile of erlotinib, together with proven efficacy in all patient subgroups and oral dosing, distinguishes erlotinib from other agents in this setting and could provide greater treatment choice for clinicians," the researchers concluded.

More information

The American Cancer Society has details about non-small-cell lung cancer.



-- Randy Dotinga



SOURCE: The Lancet Oncology, news release, May 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Book Delivers Latest ADHD Research, Treatments & Results
2. Early Treatment With Clot-Busting Drug Best After Stroke
3. CIGNA and Cancer Treatment Centers of America Reach New Agreement
4. New hope for better treatment for a rising cancer
5. Passages to Recovery Outdoor Addiction Treatment Program Achieves Joint Commission Accreditation
6. New technology aids in prostate cancer treatment
7. Impotence Drugs May Aid Brain Tumor Treatment
8. Self-directed behavioral IBS treatment rapidly relieves even the most severe symptoms
9. Researchers discover new way to rescue treatment sensitivity of breast cancer cells
10. Smarter use of existing treatment helps dramatically boost survival of young AML patients
11. Med Spa Treatments Become More Popular as Unemployment Rates Climb
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology: